Lead Plaintiff Deadline: August 17, 2020
Please Upload related files below
Fill in below.
Looking for more?
According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company’s main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics’ stock while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics’ fraudulent misstatements displayed a disregard for the basic scientific principles and cost investors to lose millions of dollars.
In order to be included in the lawsuit, you must have incurred a loss on shares of Co-Diagnostics purchased during the class period listed above.
If you suffered a loss in Co-Diagnostics during the relevant time frame, you have until August 17, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.